Ra Medical Systems was founded in 2002 by Dean Irwin and Melissa Burstein to design, develop, and commercialize excimer lasers for the treatment of dermatologic and cardiovascular diseases. Its flagship product, Pharos, launched in 2004 and revolutionized the dermatology world with its technological advancements and game-changing business model of affordable ownership with unlimited use.

Staying true to the values upon which the company was founded, Ra Medical Systems continued to be a private, clinically-oriented, scientifically-driven organization, focusing on self-funding its growth organically and sustainably. Maintaining profitability year after year by strategic cost management while exponentially growing revenue from Pharos laser sales in the US and internationally, profits were reinvested internally to fund the development of its cardiovascular laser and catheters.

In 2012, the first patients were treated with Ra Medical Systems’ cardiovascular DABRA catheter and laser system in a pilot study conducted outside the United States.

Over the past decade, Pharos has helped hundreds of thousands of patients triumph over difficult-to-treat skin diseases and gain more confidence in their appearance and themselves. Ra Medical Systems’ Pharos has transformed their lives.